World's Best Scientists 2026 revealed!

D-Index & Metrics

Best Female Scientists

D-Index
107
Citations
44341
World Ranking
1011
National Ranking
28

Medicine

D-Index
109
Citations
47766
World Ranking
5741
National Ranking
214

Overview

Elisabeth G.E. de Vries is affiliated with the University Medical Center Groningen in the Netherlands. Their research primarily revolves around the field of medicine, with a strong focus on oncology and radiology, nuclear medicine, and imaging. Additional research interests extend into economics and econometrics, molecular biology, and pulmonary and respiratory medicine.

The scientist's work covers several main topics, including:

  • Cancer Immunotherapy and Biomarkers
  • Medical Imaging Techniques and Applications
  • Economic and Financial Impacts of Cancer
  • Radiopharmaceutical Chemistry and Applications
  • CAR-T cell therapy research
  • Health Systems, Economic Evaluations, Quality of Life
  • Monoclonal and Polyclonal Antibodies Research

Frequent co-authors collaborating with Elisabeth G.E. de Vries include:

  • Rudolf S.N. Fehrmann (27 joint publications)
  • Sjoukje F. Oosting (26 joint publications)
  • Adrienne H. Brouwers (25 joint publications)
  • Mathilde Jalving (23 joint publications)
  • Geke A.P. Hospers (18 joint publications)

Their research has been regularly published in several notable scientific venues, among which the most frequent are:

  • Annals of Oncology (15 publications)
  • Clinical Cancer Research (10 publications)
  • Journal of Nuclear Medicine (9 publications)
  • ESMO Open (9 publications)
  • The Lancet Oncology (7 publications)

Selected recent papers include:

  • "Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma," 2022, Nature Medicine
  • "Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus," 2020, Annals of Oncology
  • "COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety," 2022, Nature Reviews Clinical Oncology
  • "Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey," 2021, The Lancet Oncology
  • "Whole-body CD8+ T cell visualization before and during cancer immunotherapy: a phase 1/2 trial," 2022, Nature Medicine

Best Publications

  • Everolimus for Advanced Pancreatic Neuroendocrine Tumors

    James C. Yao;Manisha H. Shah;Tetsuhide Ito;Catherine Lombard Bohas

  • iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics

    Lesley Seymour;Jan Bogaerts;Andrea Perrone;Robert Ford

  • RECIST 1.1—Update and clarification: From the RECIST committee

    Lawrence H. Schwartz;Lawrence H. Schwartz;Saskia Litiere;Elisabeth G. E. de Vries;Robert Ford

  • Response assessment criteria for brain metastases: proposal from the RANO group

    Nancy U Lin;Eudocia Q Lee;Hidefumi Aoyama;Igor J Barani

  • Evidence based selection of housekeeping genes

    Hendrik J. M. de Jonge;Rudolf S. N. Fehrmann;Eveline S. J. M. de Bont;Robert M. W. Hofstra

  • A review on CXCR4/CXCL12 axis in oncology: No place to hide

    Urszula M. Domanska;Roeliene C. Kruizinga;Wouter B. Nagengast;Hetty Timmer-Bosscha

  • 89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer

    Frederike Bensch;Elly L. van der Veen;Marjolijn N. Lub-de Hooge;Annelies Jorritsma-Smit

  • Metformin: taking away the candy for cancer?

    Mathilde Jalving;Jourik A. Gietema;Joop D. Lefrandt;Steven de Jong

  • Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study.

    Udai Banerji;Carla M L van Herpen;Cristina Saura;Fiona Thistlethwaite

  • Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro.

    Mwn Nijsten;P Olinga;Ege de Vries

  • Indium-111–Labeled Trastuzumab Scintigraphy in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer

    Patrick J. Perik;Marjolijn N. Lub-De Hooge;Jourik A. Gietema;Winette T.A. van der Graaf

  • In Vivo VEGF Imaging with Radiolabeled Bevacizumab in a Human Ovarian Tumor Xenograft

    Wouter B. Nagengast;Elisabeth G. de Vries;Geke A. Hospers;Nanno H. Mulder

  • Increased cancer risk after liver transplantation: a population-based study.

    Elizabeth B Haagsma;Vincent E Hagens;Michael Schaapveld;Aad P van den Berg

  • Gene expression analysis identifies global gene dosage sensitivity in cancer

    Rudolf S. N. Fehrmann;Juha M. Karjalainen;Małgorzata Krajewska;Harm-Jan Westra

  • Development and characterization of clinical-grade 89Zr-trastuzumab for HER2/neu immunoPET imaging.

    Eli C. F. Dijkers;Jos G. W. Kosterink;Anna P. Rademaker;Lars R. Perk

  • Immuno-PET: A Navigator in Monoclonal Antibody Development and Applications

    Guus A.M.S. van Dongen;Gerard W.M. Visser;Marjolijn N. Lub-de Hooge;Elisabeth G. de Vries

  • Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma.

    Mirjam J. A. Engelen;Henrike E. Kos;Pax H. B. Willemse;Jan G. Aalders

  • Tumor-associated macrophages in breast cancer : Innocent bystander or important player?

    Si-Qi Qiu;Stijn J.H. Waaijer;Mieke C. Zwager;Elisabeth G.E. de Vries

  • Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer.

    Rico Rd Bense;Christos Sotiriou;Martine Piccart-Gebhart;John B A G Jb Haanen

  • Molecular and Clinical Characteristics of MSH6 Variants: An Analysis of 25 Index Carriers of a Germline Variant

    Maran J.W. Berends;Ying Wu;Rolf H. Sijmons;Rob G.J. Mensink

Frequent Co-Authors

Harry Hollema
Harry Hollema University Medical Center Groningen
Jan H. Kleibeuker
Jan H. Kleibeuker University Medical Center Groningen
Edo Vellenga
Edo Vellenga University Medical Center Groningen
Harry J.M. Groen
Harry J.M. Groen University Medical Center Groningen
Gerard J. te Meerman
Gerard J. te Meerman University Medical Center Groningen
Rudi Dierckx
Rudi Dierckx University Medical Center Groningen
Otto S. Hoekstra
Otto S. Hoekstra Amsterdam UMC
Robert M.W. Hofstra
Robert M.W. Hofstra Erasmus University Rotterdam
Henk M.W. Verheul
Henk M.W. Verheul Radboud University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in Medicine doesn’t always mean becoming a physician. There are diverse online degree options in healthcare, each with unique pathways, time commitments, and admission requirements.

If you’re interested in healthcare administration, explore cahme accredited online mha programs, which prepare you for leadership roles in hospitals and healthcare systems. For registered nurses seeking career advancement, some rn to bsn programs without clinicals allow you to finish your bachelor’s degree entirely online, offering flexibility for working professionals.

Ambitious nurses can fast-track their education with shortest dnp programs online, earning a Doctor of Nursing Practice quickly to qualify for top clinical or leadership roles. If you prioritize accessibility and support, community ratings highlight some as the easiest dnp program reddit options, ideal if you’re searching for smoother journeys through advanced practice education.

Exploring these alternative online healthcare degrees can help you find the best fit for your goals, balancing convenience, career progression, and your personal circumstances.

Best Scientists Citing Elisabeth G.E. de Vries

Trending Scientists